Cetuximab for recurrent and/or metastatic squamous cell carcinoma of the head and neck: a NICE single technology appraisal.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Works matching IS 11707690 AND DT 2010 AND VI 28 AND IP 6
Results: 8
1
2
Does the inclusion of a cost attribute result in different preferences for the surgical treatment of primary basal cell carcinoma?: a comparison of two discrete-choice experiments.
- Published in:
- 2010
- By:
- Publication type:
- journal article
3
Does the Inclusion of a Cost Attribute Result in Different Preferences for the Surgical Treatment of Primary Basal Cell Carcinoma?
- Published in:
- PharmacoEconomics, 2010, v. 28, n. 6, p. 507, doi. 10.2165/11532240-000000000-00000
- By:
- Publication type:
- Article
4
Understanding the Relationship between the EQ-5D, SF-6D, HAQ and Disease Activity in Inflammatory Arthritis.
- Published in:
- PharmacoEconomics, 2010, v. 28, n. 6, p. 477, doi. 10.2165/11533010-000000000-00000
- By:
- Publication type:
- Article
5
Cost Effectiveness of 5-Alpha Reductase Inhibitors for the Prevention of Prostate Cancer in Multiple Patient Populations.
- Published in:
- PharmacoEconomics, 2010, v. 28, n. 6, p. 489, doi. 10.2165/11531780-000000000-00000
- By:
- Publication type:
- Article
6
Methodological Concerns with Economic Evaluations of Meningococcal Vaccines.
- Published in:
- PharmacoEconomics, 2010, v. 28, n. 6, p. 449, doi. 10.2165/11535280-000000000-00000
- By:
- Publication type:
- Article
7
Cetuximab for Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck.
- Published in:
- PharmacoEconomics, 2010, v. 28, n. 6, p. 439, doi. 10.2165/11532220-000000000-00000
- By:
- Publication type:
- Article
8
Are Cancer Drugs Less Likely to be Recommended for Listing by the Pharmaceutical Benefits Advisory Committee in Australia?
- Published in:
- PharmacoEconomics, 2010, v. 28, n. 6, p. 463, doi. 10.2165/11533000-000000000-00000
- By:
- Publication type:
- Article